-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Stoke Therapeutics with Buy Rating, Announces Price Target of $30

Benzinga·07/18/2025 11:50:34
Listen to the news
Jefferies analyst Andrew Tsai initiates coverage on Stoke Therapeutics (NASDAQ:STOK) with a Buy rating and announces Price Target of $30.